Replicating adenoviral vectors (RAds) hold great promise for the treatment of cancer. Significant therapeutic effects of these vectors do not only rely on tumor targeting but also on efficient release of viral progeny from host cells. Cytotoxic genes expressed late in the adenoviral life cycle can significantly enhance viral release and spreading. Therefore, an adenoviral cloning system that allows easy integration of established tumor targeting techniques together with late expression of transgenes can be a valuable tool for the development of RAds. We expanded the features of the widely used AdEasy adenoviral cloning system toward the production of tropism modified replicating adenoviral vectors that express transgenes late in the viral life cycle. Three vectors (pIRES, pFIBER and pAdEasy-Sce) that facilitate easy manipulation of the adenoviral fiber region were established. Unique BstBI and I-Sce-1 restriction sites facilitate the introduction of retargeting peptides in the fiber HI-loop and of genes of interest in the fiber transcription unit. We validated the system by constructing an E1-positive adenovirus with an RGD motif in the fiber HI-loop and green fluorescent protein (GFP) expressed from the fiber transcription unit (AdD24Fiber-rgd-GFP). Additionally, assessment of E1-negative replication-deficient vectors confirmed strict dependence upon E1 expression for the expression of transgenes inserted into the fiber transcription unit. This flexible cloning system allows for straightforward construction of tropism expanded replicating adenoviral vectors that express transgenes late in the adenoviral life cycle. Replicating adenoviruses (RAds) hold great promise for the treatment of cancer, and much effort is being invested in restricting viral activity to tumor cells using transcriptional and transductional targeting. [1] [2] [3] [4] Transductional targeting increases viral entry into tumors that express low levels of the primary adenoviral receptor CAR (coxsackievirus and adenovirus receptor) resulting in improved oncolytic efficiency of replicating adenoviral vectors. [5] [6] [7] However, significant therapeutic effects do not only rely on tumor targeting but also on optimal viral control of host cell survival. Depending on the stage of the adenoviral life cycle, wild-type adenovirus either prolongs or shortens host cell survival. Early in the viral life cycle, during the production of progeny virus, host cell survival is prolonged by the expression of adenoviral proteins that preserve cell viability. In contrast, once the viral life cycle is complete, cytotoxic adenoviral proteins are expressed that stimulate viral release by initiating cell death. A clear example of such a late expressed cytotoxic gene is the adenoviral death protein (E3 11.6 kDa protein) that is required for efficient cell death and subsequent release and spreading of progeny virus. 8, 9 Indeed, several publications have shown that late expression of cytotoxic genes, either adenoviral or nonadenoviral, significantly enhances adenoviral release and spreading. 8, [10] [11] [12] Additionally, retargeting strategies that employ bispecific antibodies or CAR fusion proteins may also benefit from expression late in the viral life cycle. 13 Therefore, replicating adenoviruses in which transgene expression is restricted to the later phases of the viral life cycle could have improved therapeutic efficacy.
Since the AdEasy system is one of the most widely used adenoviral cloning systems, we chose to expand this system to facilitate the construction of recombinant replicating adenoviruses with a modified fiber region.
14, 15 The system we developed allows for easy introduction of the following features: (1) transgene expression late in the viral life cycle, (2) retargeting peptides in the HI-loop of the fiber knob and (3) introduction of the (modified) adenoviral E1 region. 5, 16 Transgene expression can be restricted to the final stage of the adenoviral life cycle by internal ribosomal entry site (IRES)-mediated incorporation into the adenoviral fiber transcription unit. 17 To simplify insertion of transgenes in the fiber transcription unit, we constructed three plasmids: pIRES, pFIBER and pAdEasy-Sce ( Figure  1a) . Plasmid pIRES contains an IRES-eGFP (enhanced green fluorescent protein) cassette flanked by I-Sce-1 restriction sites. Unique NcoI and NotI restriction sites in pIRES can be used to replace the eGFP gene or, alternatively, NotI and EcoRI can be used to replace the Figure 1 (a) Schematic representation of pIRES, pFIBER and pAdEasy-Sce used to construct fiber region-modified E1/E3-deleted adenovirus serotype 5 genomes. Note that for clarity of the overall cloning scheme, the eGFP gene, which is flanked by the NcoI-NotI sites of pIRES, is not depicted. Also note that pAdEasy-Sce is depicted after linearization with I-Sce-1 (L/RITR: left and right adenoviral inverted terminal repeat; Ori: E. coli origin of replication). Construction of pIRES: XhoI/I-Sce-1/EcoRi (oligos: 5 0 -tcgagtagggataacagggtaatg-3 0 and 5 0 -aattcattaccctgttatccctac-3 0 ) and NotI/I-Sce-1/SacI (oligos: 5 0 -ggccgctagggataacagggtaatgagct-3 0 and 5 0 -cattaccctgttatccctagc-3 0 ) linkers were used to introduce unique I-Sce-1 restriction sites flanking the encephalomyocarditis virus (emcv)IRES-eGFP cassette of pBSK-iresGFP (gift from AQ Bakker, the Netherlands Cancer Institute). Construction of pFIBER: The adenoviral fiber protein containing the 5944 bp EcoRI fragment of pAdHM15 (gift from Dr H Mizuguchi, National Institute of Health Sciences, Japan) was ligated into pCR2.1 (InVitrogen) yielding pCR2.1FIBER. 16 A unique I-Sce-1 restriction site was introduced following the adenoviral fiber stop codon by overlapping PCR. The following primers were used: primer pair 1: forward 5 0 -cggtacacaggaaacaggagac-3 0 , reverse 5 0 -attaccctgttatccctattattcttgggcaatg-3 0 (166 bp amplicon) and primer pair 2: forward 5 0 -tagggataacagggtaatagaatcgtttgtgttatg-3 0 , reverse 5 0 -cgaatcatcgct gaggagac-3 0 (558 bp amplicon). I-Sce-1 sites are underlined. Both fragments were combined for a third PCR using the outside primers. The resulting fragment was cloned, sequenced and introduced into pCR2.1FIBER with BstBI-BlpI yielding pFIBER. Construction of pAdEasy-Sce: Plasmid pAdEasySce is identical to pAdEasy-1 (E1/E3-deleted adenoviral serotype 5 genome) with the addition of a unique I-Sce-1 restriction site following the adenoviral fiber stop codon. 15 A 1782 bp I-Sce-1-containing fragment was released from pFIBER with EcoRV-HpaI and cotransformed with pAdEasy-1 into E. coli strain BJ5183. 15, 26, 27 Single-colony-derived plasmids were subjected to restriction analyses. Construction of pAdEasy transgene: The vesicular stomatitis virus glycoprotein gene was amplified from retroviral packaging plasmid pMD.G-primers: forward 5 0 -ccatggagtgctttttgtacttagc-3 0 , reverse 5 0 -gcggccgcttaccttccaagtcggttc-3 0 (Nco-1 and Not-1 sites are underlined) -sequenced and used to replace eGFP in pIRES yielding pIRES-VSVG. 28 IRES transgene cassettes, released from pIRES with I-Sce-1, were cloned into pFIBER. Introduction of an Arg-Gly-Asp (RGD) motif in the fiber HI-loop was performed as described previously using pFIBER as recipient. 16 Subsequently, the IRES-containing HpaI-EcoRV fragment released from pFIBER plasmids was cotransformed with I-Sce-1-linearized pAdEasy-Sce into E. coli strain BJ5183 yielding pAdEasy-GFP, pAdEasy-rgd-GFP and pAdEasy-VSVG. (b) Replication-competent adenoviruses. AdD24Fiber and AdD24Fiber-rgd-GFP were produced by homologous recombination of the appropriate AdEasy backbone (pAdEasy-1, pAdEasy-rgd-GFP) with an AdEasy shuttle plasmid containing the adenoviral E1 region with a 24 bp deletion in constant region 2 (pShuttleD24, gift from Dr VW van Beusechem, VU University Medical Center, the Netherlands). 15, 19 Viruses were prepared in CC-LP-1 cells. Crude viral stocks were prepared by three freeze-thaw cycles of producer cells resuspended in PBS. Lysates were clarified by centrifugation (10 min, 2000 r.p.m., Hettich rotina 46R centrifuge) and filtration over a 0.45 mm filter (Millipore), aliquoted and stored at À801C. Viral titers were expressed as CC-LP-1 transducing units per ml as determined by adenovirus protein-expressing cells at 48 h post-transduction as previously described by Bewig and Schmidt. 29 CC-LP-1 cells do not contain the E1 region, are very susceptible to adenoviral transduction and express amounts of CAR that are comparable to HEK293 (data not shown). (c) Replication-deficient adenoviral vectors used for characterization of the cloning system. Electrocompetent BJ5183 E. coli cells containing pAdEasy transgene plasmids were established and a DsRed marker gene (derived from pDsRed1-N1; Clontech) was introduced into the E1 region by homologous recombination with pShuttle CMV Ds Red. 15, 18 Viral vectors were prepared in the E1-positive adenovirus producer cell line HEK293. Crude viral stocks were prepared as described in (b). All viral titers were expressed as CC-LP-1 cell transducing units per ml (TU/ml) as determined by flow cytometry for DsRed (Becton Dickinson FACS Calibur, FL-2 channel) 60 h post-transduction.
AdEasy-based cloning enabling late expression of transgenes M Lie-A-Ling et al complete IRES-containing cassette (Figure 1a) . The IRES expression cassette can be inserted into the adenoviral fiber transcription unit via I-Sce-1-mediated cloning into pFIBER. Plasmid pFIBER contains the final 5987 bp of the E3-deleted right arm of adenovirus serotype 5, with the addition of a unique I-Sce-1restriction site following the fiber stop codon. The nonpalindromic I-Sce-1 recognition sequence ensures that pIRES-derived cassettes can only be linked to the 3 0 end of the adenoviral fiber coding sequence in an 'IRES first' orientation. Additionally, the unique BstBI site in pFIBER facilitates the insertion of retargeting peptides into the HI-loop as previously described by Mizuguchi et al. 16 The fiber region, including HI-loop modification and IRES transgene insertions, can be released from pFIBER with HpaI and EcoRV and introduced into pAdEasy-Sce by homologous recombination in Escherichia coli strain BJ5183 (Figure 1) . 14, 15 Upon cotransformation of I-Sce-1-linearized pAdEasy-Sce together with the HpaI-EcoRV insert (molar ratio 1:175) routinely at least 15% of recovered plasmid was found to be correctly recombined. Recombinant E1/E3-deleted adenoviral genomes containing the engineered fiber region can be used to establish electrocompetent BJ5183 cells as described by Zeng et al. 18 This facilitates easy homologous recombination-based introduction of the adenoviral E1 region of choice using the standard AdEasy shuttle system. 15 To validate our cloning system, we constructed a replication-competent adenovirus, AdD24Fiber-rgd-GFP. This virus contains the RGD retargeting motif in the fiber HI-loop and the eGFP in the fiber transcription unit. Furthermore, this virus contains a 24-bp-deleted E1 region (D24) that has been shown to provide preferential replication of the virus in tumor cells. 19 Homologous recombination of the appropriate E1/E3-deleted adenoviral genome (pAdEasy-1, pAdEasy-rgd-GFP) with an AdEasy shuttle plasmid containing the D24 E1 region yielded AdD24Fiber and AdD24Fiber-rgd-GFP ( Figure  1b) . Western blot analyses of E1-negative CC-LP-1 cells infected with AdD24Fiber-rgd-GFP shows that eGFP becomes detectable 24-h postinfection and, like the fiber protein, is expressed late in the viral life cycle (Figure 2a) . The reverse was seen for E1A proteins, which are known to be downregulated in the later stages of the adenoviral life cycle (Figure 2a) . 17, 20 These results confirm the late expression of the transgene in the fiber transcription unit. 
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Expression of fiber, and other late expressed adenoviral proteins, is strictly dependent on the initiation of replication by the E1 region. 20 To confirm that this is also the case in our cloning system, we constructed an adenoviral vector in which the E1 region was replaced by a CMVdsRed expression cassette (AdFiber-GFP in Figure 1c ). In this replication-deficient vector, fiber and fiber-linked transgene expression is expected to occur only in E1-positive cell lines. To demonstrate that fiberlinked transgene expression depends on E1 expression, E1-positive cell lines (HEK293, HER911, GH329) and E1-negative cell lines (HeLa and CC-LP-1) were transduced with AdFiber-GFP and analyzed for DsRed and eGFP expression by flow cytometry. [21] [22] [23] [24] E1-negative cells were transduced with higher multiplicities of infection (MOIs) and analyzed at later time points (at least 3 days post-transduction) to ensure that low levels of background expression could be detected. Still as expected and summarized in Table 1 , no detectable eGFP expression was observed in E1-negative cells while both single-(DsRed) and double-(DsRed and eGFP) positive cells were detected in E1-positive cells. This was also confirmed by Western blotting, where no fiber, eGFP or E1A protein expression was detected in E1-negative cells (HeLa, data not shown), while in E1-positive HER911 cells the expression of eGFP in the fiber transcription unit mimics that of the fiber (Figure 2b) . Subsequently, to confirm NcoI-NotI-mediated cloning into pIRES, we inserted the vesicular stomatitis virus glycoprotein (AdFiber-VSV-G) into the fiber transcription unit and confirmed by Western blotting that the expression of this transgene also depends on the presence of E1 (Figure 2c) . Additionally, the introduction of VSV-G demonstrates that at least up to 2156 bp (VSV-G and IRES sequence) can be cloned into the fiber transcription unit. This suggests that size restrictions will not limit the introduction of bispecific antibodies or CAR fusion proteins into the fiber transcription unit using this cloning system. 13 Together, these data confirm that fiber-linked transgene expression is dependent on E1 expression and is induced, together with fiber, late in the adenoviral life cycle.
Next, we confirmed that the RGD tropism expansion is functional within our cloning system. Insertion of the RGD peptide in the adenoviral fiber HI-loop has been shown to result in adenoviral vectors that efficiently transduce cells independent of the CAR by retargeting viral attachment to intergrins. 5, 16, 25 Therefore, we assessed the cytotoxicity of AdD24Fiber and AdD24Fiber-rgd-GFP on the CAR-positive cell line CC-LP-1 and the CAR-negative cell line HS-766T. 25 Toxicity of both vectors was similar on the CAR-positive cell line CC-LP-1 (Figure 3a) . However, in the CAR-negative cell line HS766-T, AdD24Fiber-rgd-GFP was clearly more toxic than AdD24Fiber (Figure 3a) , indicating that the tropism expanded AdD24Fiber-rgd-GFP efficiently transduces CAR-negative cells. To confirm that the insertion of the RGD peptide results in more efficient transduction, we used the replication-deficient vectors AdFiber-GFP and AdFiber-rgd-GFP (Figure 1c) . Except for the replacement of the D24 E1 region with a CMV-DsRed expression cassette, AdFiber-rgd-GFP is identical to AdD24Fiber-rgd-GFP ( Figure 1b) . As expected and in concordance with the results of the cytotoxicity assay, the CARnegative cell line HS766-T was more susceptible to transduction by AdFiber-rgd-GFP compared to AdFiber-GFP (Figure 3b) . Finally, to confirm that the insertion of the RGD motif results in CAR-independent transduction, we blocked the CAR with soluble adenoviral knob protein. This inhibits transduction by AdFiber-GFP, but does not affect AdFiber-rgd-GFP transduction of the CAR-expressing cell lines CC-LP-1 and HER 911 ( Figure  3b ). Additionally and in concordance with the data presented in Figure 2 and Table 1 , eGFP expression is detected in E1-positive HER911 cells but not in the E1-negative CC-LP-1 and HS766-T cells, illustrating that E1-dependent transgene expression is maintained in AdFiber-rgd-GFP (Figure 3b) . Together, these data confirm that with this cloning system retargeting peptides can be introduced into the fiber HI-loop to generate tropism expanded (replicating) adenoviral vectors.
In conclusion, we have developed a recombination-based cloning system to produce tropism expanded replicating adenoviral vectors that express transgenes late in the viral life cycle. This flexible cloning system, which is fully compatible with the AdEasy adenoviral cloning system, can be a valuable tool for the further development of potent conditionally replicating adenoviral vectors for cancer therapy. Adenoviral transductions were routinely performed in a 300 ml inoculum for 2 h on 5 Â 10 4 cells in 24-well plates. An MOI of 0.1 was used for E1-positive cell lines (HEK293, HER911, GH329) and an MOI of 1 was used for E1-negative cell lines (HeLa, CC-LP-1). E1-linked expression of eGFP in the fiber transcription unit was determined by flow cytometry for both DsRed and eGFP. No single eGFP-positive cells were detected (Becton Dickinson FACS Calibur, FL-1 and FL-2 channel).
AdEasy-based cloning enabling late expression of transgenes M Lie-A-Ling et al Figure 3 (a) AdD24Fiber-rgd-GFP displays a higher cytotoxic effect than AdD24Fiber in CAR-negative HS766-T cells while both display equal cytotoxicity in CAR-positive CC-LP-1 cells. Based on titers determined on CC-LP-1 cells, both CC-LP-1 (high CAR expression) and HS766-T (low CAR expression) cells were transduced with different MOIs (1, 0.1 and 0.01). To visualize the cytotoxic effects, plates were rinsed once with PBS, fixed and stained with 50% methanol, 10% glacial acetic acid, 0.1% Coomassie brilliant blue G250 (Bio-Rad) at the indicated time points post-transduction.
(b) AdFiber-rgd-GFP displays CAR-independent transduction and E1-dependent transgene expression. E1-negative HS766-T (low CAR expression, top graph) and CC-LP-1 (high CAR expression, middle graph) were transduced with an MOI of 0.5 (CC-LP-1 transducing units) in the presence or absence of adenovirus serotype 5 fiber knob protein (ad5 knob). At 60 h post-transduction, the cells were analyzed by flow cytometry for eGFP and DsRed. E1-positive HER911 cells (bottom graph) were transduced with 50% efficiency using AdFiber-rgd-GFP and AdFiber-GFP. Transductions were performed in the presence or absence of ad5 knob. At 24 h post-transduction, the cells were analyzed by flow cytometry for eGFP and DsRed. All experiments were performed in triplicate in a 24-well format (5 Â 10 4 cells/well). CAR blocking was performed with 10 mg ad5 knob per well.
AdEasy-based cloning enabling late expression of transgenes M Lie-A-Ling et al
